WinRho® SDF Liquid

Product Specs WinRho® SDF Liquid
Manufacturer Name Cangene Corp
Indications Children with chronic or acute ITP, adults with chronic ITP, or children and adults with ITP secondary to HIV infection, and suppression of Rh Isoimmunization.
  • Patients who have had known anaphylactic or severe systemic reaction to the administration of human immune globulin products.
  • IgA deficient patients with antibodies to IgA and a history of hypersensitivity.
  • Patients with autoimmune hemolytic anemia, with pre-existing hemolysis or at high risk for hemolysis. Infants for the suppression of Rho(D) isoimmunization.
  • Viral Safety Process Solvent/detergent, nanofiltration, anion exchange column chromatography
    Route of Administration IV or IM depending on indication
    Clearance of Rh-positive Red Blood Cells A 1500 IU dose will suppress the immunizing potential of approximately 17 mL of RhoD positive RBCs
    Product Half-Life 24 days IV, 30 days IM
    Latex Content No
    Thimerosal Content No, there are no preservatives, including mercury-based or thimerosal-based preservatives in the formulation.
    Storage Requirements/Shelf Life
  • Refrigerate at 2°C to 8°C (36°F to 46°F).
  • Do not use past expiration date listed on label.
  • Protect from light.
  • Do not freeze.
  • Supply Method Vial
    Available Sizes 1500 IU (300 mcg)
    2500 IU (500 mcg)
    5000 IU (1000 mcg)
    15000 IU (3000 mcg)

    Return to Manufacturer Name listing Return to Factor Type listing